News

Clinical & Regulatory,Pharmaceuticals and therapeutics,Therapeutic Areas
ViiV’s Cabenuva shows superior HIV control to daily oral therapy in adolescents
read more
Biotech & Pharma Business,Digital & Data,Drug Discovery & Development,Research & Development
Qureight raises $20 million to expand AI imaging platform into new lung and heart diseases
read more
Clinical & Regulatory,Digital & Data,Medical devices,Research & Development
Caristo Diagnostics’ CaRi-Heart coronary inflammation technology authorised by US FDA
read more
Clinical & Regulatory
European HIV survey finds gap in long-acting treatment conversations
read more
Clinical & Regulatory,Digital & Data,Medical devices
ThinkSono wins FDA clearance for AI-guided ultrasound software for suspected DVT
read more
Central Nervous System,Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Research & Development
ProMIS reports no ARIA-E in Phase 1b Alzheimer’s trial of PMN310
read more
Biotech & Pharma Business,Digital & Data,Drug Delivery & Formulation,Pharmaceuticals and therapeutics
PolyPid’s D-PLEX100 receives FDA Priority Review for surgical site infection prevention
read more
Drug Discovery & Development,Manufacturing & Supply Chain,Medical devices,Research & Development
New air filter coating boosts particle capture and doubles filter lifespan
read more
Biotech & Pharma Business,Digital & Data,Drug Discovery & Development,Research & Development
Qureight raises $20 million to expand AI imaging platform for clinical trials
read more
Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Research & Development
HAYA Therapeutics wins FDA Fast Track designation for HTX-001 in heart disease
read more
Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Research & Development
Amorphical completes Phase 2 enrolment for AMOR-1 in hypoparathyroidism
read more
Biotech & Pharma Business,Clinical & Regulatory,Pharmaceuticals and therapeutics,Research & Development
Claris Bio raises $118 million to advance potential first drug treatment for LSCD
read more
Drug Delivery & Formulation,Drug Discovery & Development,Manufacturing & Supply Chain,Pharmaceuticals and therapeutics,Research & Development
ProBioGen and VarmX partner on second Factor X candidate
read more
Medical devices,Research & Development
Quantum-enhanced MRI project targets higher-resolution brain metastases imaging
read more
Biotech & Pharma Business,Manufacturing & Supply Chain,Research & Development,Uncategorised
China biotech growth faces US policy scrutiny despite scientific progress
read more
Clinical & Regulatory,Drug Delivery & Formulation,Pharmaceuticals and therapeutics,Research & Development
FDA allows Medicus Pharma to start SkinJect study in patients with Gorlin Syndrome
read more

ViiV’s Cabenuva shows superior HIV control to daily oral therapy in adolescents

Qureight raises $20 million to expand AI imaging platform into new lung and heart diseases

Caristo Diagnostics’ CaRi-Heart coronary inflammation technology authorised by US FDA

European HIV survey finds gap in long-acting treatment conversations

ThinkSono wins FDA clearance for AI-guided ultrasound software for suspected DVT

ProMIS reports no ARIA-E in Phase 1b Alzheimer’s trial of PMN310

PolyPid’s D-PLEX100 receives FDA Priority Review for surgical site infection prevention

New air filter coating boosts particle capture and doubles filter lifespan

Qureight raises $20 million to expand AI imaging platform for clinical trials

HAYA Therapeutics wins FDA Fast Track designation for HTX-001 in heart disease

Amorphical completes Phase 2 enrolment for AMOR-1 in hypoparathyroidism

Claris Bio raises $118 million to advance potential first drug treatment for LSCD

ProBioGen and VarmX partner on second Factor X candidate

Quantum-enhanced MRI project targets higher-resolution brain metastases imaging

China biotech growth faces US policy scrutiny despite scientific progress

FDA allows Medicus Pharma to start SkinJect study in patients with Gorlin Syndrome

main menu

recent posts

Fuse Diagnostics raises £1M to scale rapid molecular testing platform

Amyl Therapeutics raises €8.25M to advance pan-amyloid neurodegenerative disease platform

CluePoints brings AI-powered clinical data review to DPHARM 2026

get connected